Records containing: Subcutaneous Fat
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.
-
CLINICAL_TRIALS study record update · 2024-12-05A Phase 2b, Randomized, Placebo-Controlled Factorial Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection Compared With CBL-A1 and CBL-A2 for Reducing Abdominal Subcutaneous Fat
-
CLINICAL_TRIALS study record update · 2024-07-22A Randomized, Placebo-Controlled, Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
-
CLINICAL_TRIALS study record update · 2024-03-28A 2-Stage Adaptive Design, Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal and Thigh Subcutaneous Fat (Stage 1)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-09-28Diagnostic Ultrasound for Measuring Fat of the Body
-
CLINICAL_TRIALS study record update · 2023-04-24A 2-Stage Adaptive Design, Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal and Thigh Subcutaneous Fat (Stage 2)
-
CLINICAL_TRIALS study record update · 2022-07-15A Phase 2 Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-01-08A 2-stage, Phase 1/2a Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat (Phase 2a)
-
CLINICAL_TRIALS study record update · 2021-01-07A 2-stage, Phase 1/2a Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat (Phase 1)
-
CLINICAL_TRIALS study record update · 2020-10-28ClinicalTrials.gov study NCT01842802
-
CLINICAL_TRIALS study record update · 2020-10-27Evaluation of the Safety and Efficacy of a Non-Invasive Disruption of Fat and Skin Tightening Using 1064nm and 940nm Wavelengths
-
CLINICAL_TRIALS study record update · 2020-10-19Allergan IIT-2019-10713 Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis
-
CLINICAL_TRIALS study record update · 2018-09-24Long-term, Follow-up Study of Subjects Who Completed Phase III Trials ATX-101-10-16 or ATX-101-10-17 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
-
CLINICAL_TRIALS study record update · 2017-05-24Effects of Cryolipolysis on Localized Adiposity: Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2015-09-02Effects of Ultrasound Cavitation Focused on Located Adiposity: Pilot Study
-
CLINICAL_TRIALS study record update · 2015-07-31Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring